Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology

Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy

(2019) Timothy E. Newhook et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis

(2019) Pierre-Emmanuel Bonnot et al.   JOURNAL OF CLINICAL ONCOLOGY

Nephrotoxic synergism of cisplatin and mitomycin-C for hyperthermic intraperitoneal chemotherapy and cytoreductive surgery

(2018) Ravish Kapoor et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Peritoneal Metastases from Gastrointestinal Cancer

(2018) Paul H. Sugarbaker   Current Oncology Reports

Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma

(2017) Lieselotte Lemoine et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Lessons learned from a phase II clinical trial of laparoscopic HIPEC for gastric cancer

(2017) Brian Badgwell et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Gastric peritoneal carcinomatosis - a retrospective review

(2017) Hwee Leong Tan et al.   World Journal of Gastrointestinal Oncology

Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer

(2016) Naruhiko Ikoma et al.   ANNALS OF SURGICAL ONCOLOGY

Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis

(2016) Daisuke Kobayashi et al.   Gastric Cancer

Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?

(2016) Dexter Yak Seng Chan et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer

(2014) L Ansaloni et al.   BRITISH JOURNAL OF CANCER

Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors

(2013) Irene Thomassen et al.   INTERNATIONAL JOURNAL OF CANCER

Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

(2012) Terence C. Chua et al.   JOURNAL OF CLINICAL ONCOLOGY

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

(2011) Xiao-Jun Yang et al.   ANNALS OF SURGICAL ONCOLOGY

The Clavien-Dindo Classification of Surgical Complications

(2009) Pierre A. Clavien et al.   ANNALS OF SURGERY

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience

(2009) Tristan D. Yan et al.   JOURNAL OF CLINICAL ONCOLOGY

Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy

(2008) Shigeki Kusamura et al.   JOURNAL OF SURGICAL ONCOLOGY